Rivastigmine in the treatment of Alzheimer's disease
- PMID: 11528167
- DOI: 10.1159/000050779
Rivastigmine in the treatment of Alzheimer's disease
Comment on
-
A 52-week study of the efficacy of rivastigmine in patients with mild to moderately severe Alzheimer's disease.Eur Neurol. 2000;44(4):236-41. doi: 10.1159/000008243. Eur Neurol. 2000. PMID: 11096224 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
